Section Arrow
CBIO.NASDAQ
- Crescent Biopharma Inc
(Financial Status)
Quotes are at least 15-min delayed:2025/06/18 01:21 EDT
Last
 13.27
-2.525 (-15.99%)
Day High 
15.96 
Prev. Close
15.795 
1-M High
27.5 
Volume 
18.83K 
Bid
12.82
Ask
13.32
Day Low
12.92 
Open
15.96 
1-M Low
14.91 
Market Cap 
10.13M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 18.05 
20-SMA 20.7 
50-SMA 22.24 
52-W High 19.32 
52-W Low 0.1406 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-46.00/-0.07
Enterprise Value
10.13M
Balance Sheet
Book Value Per Share
0.05
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
PCSAProcessa Pharmaceuticals0.26+0.0349+15.50%-- 
ACXPAcurx Pharmaceuticals0.8207+0.5136+167.24%-- 
VERVVerve Therapeutics11.38+5.11+81.50%-- 
AZTRAzitra0.2639-0.0057-2.11%0PE
NCNANuCana plc0.1236-0.0076-5.79%-- 
Quotes are at least 15-min delayed:2025/06/18 01:21 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
GlycoMimetics Inc is a clinical-stage biotechnology company. It is focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. Glycomimetics are molecules that mimic the structure of carbohydrates involved in important biological processes. Using expertise in carbohydrate chemistry and knowledge of carbohydrate biology, the company is developing a pipeline of proprietary glycomimetics that may inhibit disease-related functions of carbohydrates, such as the roles it play in inflammation, cancer, and infection.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.